Takeda: Hypercholesterolemia trials

The registry lists 12 Hypercholesterolemia studies with Takeda as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety of Lapaquistat Acetate in Subjects With HypercholesterolemiaCompletedNCT00868127Phase 3
• Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTerminatedNCT00865228Phase 2
• Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT00864643Phase 2
• Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTerminatedNCT00532558Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTerminatedNCT00532311Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaCompletedNCT00286481Phase 3
• Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.CompletedNCT00268697Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial HypercholesterolemiaTerminatedNCT00263081Phase 3
• Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.CompletedNCT00256178Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedNCT00249912Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTerminatedNCT00249899Phase 3
• Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary HypercholesterolemiaCompletedNCT00143676Phase 3